Palliative Radiotherapy in Cancer

Dear Colleagues,

Palliative radiotherapy is well known for being an essential tool for symptom relief in patients with advanced cancer. However, little space is usually given to this resource in conference events and more generally in the education and permanent training of doctors and specialists working in oncology.

Furthermore, clinical research has only marginally addressed this issue, leaving large spaces without clear scientific evidence in a scenario in which the introduction of the concept of oligometastatic disease has produced gray areas without clear guidelines. Finally, the diffusion of palliative therapies makes it urgent to define paths of integration between pharmacological-supportive treatments and radiotherapy.

We hope that this Special Issue will gather and highlight the evidence needed to help optimize clinical practice in palliative radiotherapy and in particular to improve the integration of radiotherapy with other resources available today in the field of palliative therapies. We look forward to your contributions.

Prof. Dr. Marco Cesare Maltoni
Prof. Dr. Alessio Giuseppe Morganti
Dr. Romina Rossi
Guest Editors

Costanza Maria Donati
Guest Editor Assitant

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cancers is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.